ALYSSA ALLMON: Open Payments
NPI 1982475372 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $344 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $153 |
| GENZYME CORPORATION | 3 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Inspire Medical Systems, Inc. | 3 | $86 |
| AERIN MEDICAL INC. | 2 | $70 |
| Amgen Inc. | 2 | $36 |
| Cochlear Americas | 1 | $15 |
Products named: DUPIXENT, NUCALA, INSPIRE, VIVAER STYLUS, TEZSPIRE, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE.
Industry payments across MD — which companies pay providers there.
